RAF1 and melanoma: No studies of feedback loop activation induced by refametinib have been published; however, previous studies of MEK/MAPK inhibition in BRAF-inhibitor resistant melanoma cells show that MEK inhibitors can activate AKT signalling as an escape mechanism through increased MEK/RAF activation [40].